Rituximab Recruiting Phase 1 Trials for Refractory Diffuse Large B Cell Lymphoma / Recurrent Diffuse Large B-Cell Lymphoma / Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic / Refractory Hodgkin Lymphoma / Refractory T-Cell Non-Hodgkin Lymphoma / Recurrent T-Cell Non-Hodgkin Lymphoma / Malignant Lymphomas Treatment